You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

intravesical BCG

Showing 1 - 25 of 570
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Non-muscle-invasive Bladder Cancer Trial (Gemcitabine, Docetaxel, Bacillus Calmette Guerin)

Not yet recruiting
  • Non-muscle-invasive Bladder Cancer
  • (no location specified)
Sep 9, 2022

Non-muscle-invasive Bladder Cancer Trial in Cairo (BCG, Gemcitabine)

Recruiting
  • Non-muscle-invasive Bladder Cancer
  • Cairo, Egypt
    Mohamed Fawzy Salman
Nov 19, 2022

Voiding Disorders Trial in Mansoura (Mirabegron, Propevirine, Solifenacin)

Recruiting
  • Voiding Disorders
  • Mirabegron, Propevirine, Solifenacin
  • Mansoura, Egypt
    Urology and Nephrology Center, Mansoura University
Aug 3, 2022

Intravesical BCG: is the Urinary Bladder Ready to Receive it

Not yet recruiting
  • Non-Invasive Bladder Urothelial Carcinoma
    • (no location specified)
    Jun 7, 2022

    Non-Muscle Invasive Bladder Cancer Trial in Québec (Bicalutamide, Control Arm)

    Recruiting
    • Non-Muscle Invasive Bladder Cancer
    • Québec, Canada
      CHU de Québec-Université Laval
    Jul 13, 2022

    Bladder Urothelial Carcinoma In Situ, Recurrent Bladder Urothelial Carcinoma, Stage 0a Bladder Cancer AJCC v8 Trial in Seattle

    Recruiting
    • Bladder Urothelial Carcinoma In Situ
    • +5 more
    • Acupuncture Therapy
    • +4 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    May 27, 2022

    Bladder Cancer Trial in Switzerland (Recombinant intravesical BCG (Bacillus Calmette-Guérin VPM1002BC), Atezolizumab, Cisplatin)

    Recruiting
    • Bladder Cancer
    • Recombinant intravesical BCG (Bacillus Calmette-Guérin VPM1002BC)
    • +3 more
    • Baden, Switzerland
    • +9 more
    Aug 12, 2022

    Intravesical N-803 Plus BCG in BCG-Naive Non-Muscle Invasive

    Recruiting
    • Non Muscle Invasive Bladder Cancer
    • N803 plus Bacillus Calmette-Guerin (BCG)
    • Honolulu, Hawaii
      Island Urology
    Aug 7, 2023

    Lower Urinary Tract Symptoms, Bladder Carcinoma, BCG Trial in Montreal (Pentosan Polysulfate Na 100Mg Cap, Placebo oral capsule)

    Terminated
    • Lower Urinary Tract Symptoms
    • +2 more
    • Pentosan Polysulfate Na 100Mg Cap
    • Placebo oral capsule
    • Montreal, Quebec, Canada
      Jewish General Hospital
    Feb 16, 2022

    Predicting BCG Response

    Recruiting
    • Bladder Cancer
      • Los Angeles, California
        Cedars-Sinai Medical Center
      Mar 7, 2022

      Bladder Cancer Trial in Mansoura (Intravesical Bcg, Intravesical chemo (epirubicin))

      Recruiting
      • Bladder Cancer
      • Intravesical Bcg
      • Intravesical chemotherapy (epirubicin)
      • Mansoura, DK, Egypt
        Mansoura Urology and Nephrology Center
      Dec 21, 2021

      Bacillus Calmette Guerin With Use of Different Types of Urinary

      Completed
      • Non-muscle-invasive Bladder Cancer
      • Marathon, Attica, Greece
        Themistoklis Bellos
      Jan 10, 2023

      Lower Urinary Tract Symptoms After Intravesical Therapy

      Recruiting
      • Chemotherapy Effect
      • +3 more
      • Validated questionnaires
      • Munich, Bavaria, Germany
        Nikolaos Pyrgidis
      May 3, 2023

      Non-muscle-invasive Bladder Cancer Trial in Zagreb (Gemcitabine 1000 mg, Docetaxel 37.5g)

      Active, not recruiting
      • Non-muscle-invasive Bladder Cancer
      • Gemcitabine 1000 mg, Docetaxel 37.5g
      • Zagreb, Croatia
        University Hospital Centre Zagreb
      Jan 20, 2023

      Urothelial Carcinoma, Non-Invasive Bladder Urothelial Carcinoma Trial in Tampa (Adoptive Cell Therapy with Tumor-infiltrating

      Recruiting
      • Urothelial Carcinoma
      • Non-Invasive Bladder Urothelial Carcinoma
      • Adoptive Cell Therapy with Tumor-infiltrating Lymphocytes (TIL)
      • Tampa, Florida
        Moffitt Cancer Center
      Mar 2, 2023

      NMIBC Trial in Beijing (RC48-ADC in Combination with gemcitabine)

      Recruiting
      • NMIBC
      • RC48-ADC in Combination with gemcitabine
      • Beijing, Beijing, China
        Peking University First Hosptital
      Jul 10, 2023

      Bladder Cancer Trial in San Antonio (Sirolimus)

      Completed
      • Bladder Cancer
      • San Antonio, Texas
        University of Texas Health Science Center at San Antonio
      Mar 17, 2021

      Recurrent Bladder Carcinoma, Stage 0a Bladder Urothelial Carcinoma, Stage 0is Bladder Urothelial Carcinoma Trial in Chicago (BCG

      Active, not recruiting
      Has Results
      • Recurrent Bladder Carcinoma
      • +3 more
      • BCG Solution
      • +3 more
      • Chicago, Illinois
        Northwestern University
      Sep 27, 2022

      Bladder Cancer, High Risk Superficial Trial in United States (Bacillus Calmette-Guérin (BCG))

      Completed
      • Bladder Cancer
      • High Risk Superficial
      • Bacillus Calmette-Guérin (BCG)
      • Basking Ridge, New Jersey
      • +4 more
      Feb 28, 2022

      Recurrent Bladder Carcinoma, Bladder Cancer Stage 0, Bladder Cancer Stage I Trial in Los Angeles (Pharmacokinetic Study,

      Not yet recruiting
      • Recurrent Bladder Carcinoma
      • +2 more
      • Pharmacokinetic Study
      • Recombinant EphB4-HSA Fusion Protein
      • Los Angeles, California
        USC / Norris Comprehensive Cancer Center
      Jan 31, 2023

      Superficial Bladder Cancer Trial in United States (EG-70)

      Recruiting
      • Superficial Bladder Cancer
      • Tucson, Arizona
      • +7 more
      May 11, 2022

      Non-Muscle Invasive Bladder Cancer (NMIBC) Refractory to BCG Trial in Canada, United States (TLD-1433 Bladder infusion and

      Recruiting
      • Non-Muscle Invasive Bladder Cancer (NMIBC) Refractory to BCG
      • TLD-1433 Bladder infusion and Photodynamic Therapy
      • Bala-Cynwyd, Pennsylvania
      • +10 more
      May 6, 2022

      Urothelial Carcinoma Bladder, Bladder Cancer Trial in Baltimore (Gemcitabine, Docetaxel)

      Recruiting
      • Urothelial Carcinoma Bladder
      • Bladder Cancer
      • Baltimore, Maryland
        Johns Hopkins University: Sidney Kimmel Comprehensive Cancer Cen
      Sep 9, 2021

      Bladder Cancer Trial in United States (N-803 and BCG, N-803)

      Recruiting
      • Bladder Cancer
      • Anchorage, Alaska
      • +31 more
      Oct 26, 2022

      Urothelial Carcinoma of the Urinary Bladder Trial in New York (Cabazitaxel, Gemcitabine, Cisplatin)

      Recruiting
      • Urothelial Carcinoma of the Urinary Bladder
      • New York, New York
        Columbia University Medical Center- HIP
      Feb 3, 2022